136 related articles for article (PubMed ID: 9195372)
41. The effect of hepatocyte enlargement on the hemodynamic characteristics of the isolated perfused rat liver preparation.
Grossman HJ; Grossman VL; Bhathal PS
Hepatology; 1998 Feb; 27(2):446-51. PubMed ID: 9462643
[TBL] [Abstract][Full Text] [Related]
42. Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension?
Sansoè G; Aragno M; Mastrocola R; Restivo F; Mengozzi G; Smedile A; Rosina F; Danni O; Parola M; Rizzetto M
J Hepatol; 2005 Nov; 43(5):791-8. PubMed ID: 16085334
[TBL] [Abstract][Full Text] [Related]
43. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
[TBL] [Abstract][Full Text] [Related]
44. NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver.
Fiorucci S; Antonelli E; Brancaleone V; Sanpaolo L; Orlandi S; Distrutti E; Acuto G; Clerici C; Baldoni M; Del Soldato P; Morelli A
J Hepatol; 2003 Dec; 39(6):932-9. PubMed ID: 14642608
[TBL] [Abstract][Full Text] [Related]
45. Endothelin-1-induced vasoconstriction causes a significant increase in portal pressure of rat liver: localized constrictive effect on the distal segment of preterminal portal venules as revealed by light and electron microscopy and serial reconstruction.
Kaneda K; Ekataksin W; Sogawa M; Matsumura A; Cho A; Kawada N
Hepatology; 1998 Mar; 27(3):735-47. PubMed ID: 9500702
[TBL] [Abstract][Full Text] [Related]
46. Increased blood flow through the portal system in cirrhotic rats.
Vorobioff J; Bredfeldt JE; Groszmann RJ
Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
[TBL] [Abstract][Full Text] [Related]
47. Effect of changes in vascular tone on the haemodynamic characteristics of the portal vascular bed of the isolated perfused rat liver.
Grossman HJ; Grossman VL; Bhathal PS
J Gastroenterol Hepatol; 1995; 10(4):459-64. PubMed ID: 8527714
[TBL] [Abstract][Full Text] [Related]
48. Intrahepatic microvascular changes in carbon tetrachloride-induced cirrhotic livers in the rat.
Koo A; Liang IY; Cheng KK
Aust J Exp Biol Med Sci; 1976 Jun; 54(3):277-86. PubMed ID: 1016125
[TBL] [Abstract][Full Text] [Related]
49. The ability of 17 β-estradiol to attenuate intrahepatic vasoconstriction to endothelin-1 in female rats is lost in cirrhosis.
Ho HL; Lee FY; Hsu SJ; Wang SS; Hsin IF; Huang HC; Lee JY; Lin HC; Lee SD
Ann Hepatol; 2015; 14(3):404-13. PubMed ID: 25864222
[TBL] [Abstract][Full Text] [Related]
50. Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.
Cavasin MA; Semus H; Pitts K; Peng Y; Sandoval J; Chapo J; Plato CF
Can J Physiol Pharmacol; 2010 Jun; 88(6):636-43. PubMed ID: 20628429
[TBL] [Abstract][Full Text] [Related]
51. The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis.
Fiorucci S; Antonelli E; Mencarelli A; Orlandi S; Renga B; Rizzo G; Distrutti E; Shah V; Morelli A
Hepatology; 2005 Sep; 42(3):539-48. PubMed ID: 16108046
[TBL] [Abstract][Full Text] [Related]
52. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis.
Mizumoto M; Arii S; Furutani M; Nakamura T; Ishigami S; Monden K; Ishiguro S; Fujita S; Imamura M
J Surg Res; 1997 Jul; 70(2):124-33. PubMed ID: 9245560
[TBL] [Abstract][Full Text] [Related]
53. Aliskiren reduces portal pressure and intrahepatic resistance in biliary cirrhotic rats.
Hsieh YC; Chan CC; Lee KC; Huang YT; Lee FY; Yang YY; Lin HC
J Chin Med Assoc; 2012 Oct; 75(10):501-8. PubMed ID: 23089401
[TBL] [Abstract][Full Text] [Related]
54. Role of cirrhosis in the hemodynamic response to hemorrhage in portal hypertension.
Burns RC; Wu Y; Sitzmann JV
Surgery; 1995 May; 117(5):488-93. PubMed ID: 7740418
[TBL] [Abstract][Full Text] [Related]
55. Localisation of hepatic vascular resistance sites in the isolated dual-perfused rat liver.
Yang W; Benjamin IS; Alexander B
Eur J Pharmacol; 1999 Jan; 364(1):13-21. PubMed ID: 9920180
[TBL] [Abstract][Full Text] [Related]
56. LPS exacerbates endothelin-1 induced activation of cytosolic phospholipase A2 and thromboxane A2 production from Kupffer cells of the prefibrotic rat liver.
Miller AM; Masrorpour M; Klaus C; Zhang JX
J Hepatol; 2007 Feb; 46(2):276-85. PubMed ID: 17161492
[TBL] [Abstract][Full Text] [Related]
57. Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulation in vitro and in vivo in a rat model.
Francque S; Wamutu S; Chatterjee S; Van Marck E; Herman A; Ramon A; Jung A; Vermeulen W; De Winter B; Pelckmans P; Michielsen P
Liver Int; 2010 Mar; 30(3):365-75. PubMed ID: 19840249
[TBL] [Abstract][Full Text] [Related]
58. IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats.
Zhao TY; Su LP; Ma CY; Zhai XH; Duan ZJ; Zhu Y; Zhao G; Li CY; Wang LX; Yang D
BMC Gastroenterol; 2015 Jul; 15():77. PubMed ID: 26152281
[TBL] [Abstract][Full Text] [Related]
59. Differential response of normal and cirrhotic liver to vasoactive agents. A study in the isolated perfused rat liver.
Ballet F; Chretien Y; Rey C; Poupon R
J Pharmacol Exp Ther; 1988 Jan; 244(1):283-9. PubMed ID: 3336005
[TBL] [Abstract][Full Text] [Related]
60. Calcium receptors located in fibrotic septa: a new target to reduce portal pressure in liver cirrhosis.
Sansoè G; Aragno M; Mastrocola R; Paternostro C; Parola M
Clin Sci (Lond); 2013 Jul; 125(2):67-75. PubMed ID: 23384153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
